CoChat
Sign Up
Cited by 211Clinical Nutrition and GastroenterologyHyperglycemia and glycemic control in critically ill and hospitalized patientsMuscle metabolism and nutrition

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Effects of isoenergetic glucose-based or lipid-based parenteral nutrition on glucose metabolism, de novo lipogenesis, and respiratory gas exchanges in critically ill patients

Tappy, Luc, Schwarz, Jean-Marc, Schneiter, Philippe, Cayeux, Christine, Revelly, Jean-Pierre, Fagerquist, Clifton K., Jequier, Eric, Chiolero, Rene·1998·Critical Care Medicine
DOI 10.1097/00003246-199805000-00018
Open this paper in CoChat — free account

Abstract

OBJECTIVE: To compare the effects of isocaloric, isonitrogenous carbohydrate nutrition vs. lipid-based total parenteral nutrition on respiratory gas exchange and intermediary metabolism in critically ill patients. DESIGN: Prospective, clinical trial. SETTING: Surgical intensive care unit in a major university hospital in Switzerland. PATIENTS: Sixteen patients admitted to the surgical intensive care unit. INTERVENTIONS: Patients were randomized to receive isocaloric isonitrogenous total parenteral nutrition (TPN) containing 75% (TPN-glucose) or 15% (TPN-lipid) glucose over a 5-day period. MEASUREMENTS AND MAIN RESULTS: Indirect glucose metabolism was assessed from plasma carbon-13 (13C)-labeled glucose and 13C-labeled CO2 production during a tracer infusion of uniformly 13C-labeled glucose, and de novo lipogenesis was estimated from the incorporation of 13C into palmitate-very low density lipoproteins (VLDL) during a tracer infusion of 1-(13)C acetate. Compared with TPN-lipid, TPN-glucose increased plasma glucose more (by 26% vs. 7%, p < .05), increased insulin more (by 284% vs. 40%, p < .01), and increased total CO2 more (by 15% vs. 0%, p < .01). Both nutrient mixtures failed to inhibit endogenous glucose production and net protein oxidation, suggesting absence of suppression of gluconeogenesis. Fractional de novo lipogenesis was markedly increased by TPN-glucose to 17.4% vs. 3.3% with TPN lipids. CONCLUSIONS: The rate of glucose administration commonly used during TPN of critically ill patients does not suppress endogenous glucose production or net protein loss, but markedly stimulates de novo lipogenesis and CO2 production. Increasing the proportion of fat may be beneficial, provided that lipid emulsion has no adverse effects.

Overview

Integrity signals

Registry

Crossref · 10.1097/00003246-199805000-00018

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 6

  1. Elwyn, 1993, Nutrition, 9, 50
  2. LeGall, 1993, JAMA, 270, 2957, 10.1001/jama.1993.03510240069035 · DOI · Paper page
  3. DeBodo, 1963, Recent Prog Horm Res, 19, 445
  4. Schneiter, 1995, Am J Physiol, 269, E1031
  5. Hellerstein, 1992, Am J Physiol, 263, E988
  6. Tappy, 1995, Am J Physiol, 268, E630

Cited by

Sorted by citations

See all 211

Related

See all

Metadata

Authors
Tappy, L., Schwarz, J.-M., Schneiter, P., Cayeux, C., Revelly, J.-P., Fagerquist, C. K., Jequier, E., & Chiolero, R.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
ORCID
Venue
Critical Care Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1998-05
Volume
26
Issue
5
Pages
860-867
ISSN
0090-3493 (ISSN-L)
DOI
10.1097/00003246-199805000-00018
OpenAlex
W2011859447
Cited by
211
References
25
Citations by year
2026: 4 · 2025: 4 · 2024: 12 · 2023: 18 · 2022: 4 · 2021: 9 · 2020: 9 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 7 · 2015: 9 · 2014: 6 · 2013: 4 · 2012: 3
FWCI
6.70
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
total parenteral nutrition, critically ill patients, glucose metabolism, de novo lipogenesis, pulmonary gas exchange, gluconeogenesis, protein oxidation, insulin, lipid emulsions, surgical intensive care unit
MeSH terms
Adolescent, Adult, Aged, Calorimetry, Indirect, Carbon Dioxide, Female, Glucose, Humans, Intensive Care Units, Lipids, Male, Middle Aged, Oxygen Consumption, Parenteral Nutrition, Pulmonary Gas Exchange, Wounds and Injuries, Injury Severity Score, Critical Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review